129 related articles for article (PubMed ID: 10087976)
21. Bisphosphonates for cancer patients: why, how, and when?
Body JJ; Mancini I
Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
[TBL] [Abstract][Full Text] [Related]
22. Use of bisphosphonates can dramatically improve pain in advanced hormone-refractory prostate cancer patients.
Rodrigues P; Hering F; Campagnari JC
Prostate Cancer Prostatic Dis; 2004; 7(4):350-4. PubMed ID: 15534620
[TBL] [Abstract][Full Text] [Related]
23. One-month follow-up of patients treated by intravenous clodronate for acute pain induced by osteoporotic vertebral fracture.
Rovetta G; Maggiani G; Molfetta L; Monteforte P
Drugs Exp Clin Res; 2001; 27(2):77-81. PubMed ID: 11392057
[TBL] [Abstract][Full Text] [Related]
24. Pain relief and quality-of-life assessment following intravenous and oral clodronate in hormone-escaped metastatic prostate cancer.
Cresswell SM; English PJ; Hall RR; Roberts JT; Marsh MM
Br J Urol; 1995 Sep; 76(3):360-5. PubMed ID: 7551847
[TBL] [Abstract][Full Text] [Related]
25. [Breast cancer with osteoblastic bone metastasis treated successfully with bisphosphonate: a case report].
Oura S; Sakurai T; Yoshimura G; Tamaki T; Umemura T; Kokawa Y
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1651-5. PubMed ID: 10553426
[TBL] [Abstract][Full Text] [Related]
26. [Radionuclides for metastatic bone pain palliation].
Lass P
Pol Merkur Lekarski; 2002 Oct; 13(76):277-80. PubMed ID: 12557429
[TBL] [Abstract][Full Text] [Related]
27. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
Clemons MJ; Dranitsaris G; Ooi WS; Yogendran G; Sukovic T; Wong BY; Verma S; Pritchard KI; Trudeau M; Cole DE
J Clin Oncol; 2006 Oct; 24(30):4895-900. PubMed ID: 17001071
[TBL] [Abstract][Full Text] [Related]
28. No value of oral clodronic acid in malignant osteolysis.
Prescrire Int; 1998 Aug; 7(36):104. PubMed ID: 10342946
[TBL] [Abstract][Full Text] [Related]
29. Clodronate therapy of metastatic bone disease in patients with prostatic carcinoma.
Adami S; Mian M
Recent Results Cancer Res; 1989; 116():67-72. PubMed ID: 2527401
[TBL] [Abstract][Full Text] [Related]
30. Ketorolac: continuous subcutaneous infusion for cancer pain.
Hughes A; Wilcock A; Corcoran R
J Pain Symptom Manage; 1997 Jun; 13(6):315-6. PubMed ID: 9204648
[No Abstract] [Full Text] [Related]
31. Comparison of pharmacokinetics of clodronate after single and repeated doses.
Ylitalo P; Holli K; Mönkkönen J; Elo HA; Juhakoski A; Liukko-Sipi S; Ylitalo R
Int J Clin Pharmacol Ther; 1999 Jun; 37(6):294-300. PubMed ID: 10395121
[TBL] [Abstract][Full Text] [Related]
32. Double-blind, placebo-controlled, dose-response trial of oral clodronate in patients with bone metastases.
O'Rourke N; McCloskey E; Houghton F; Huss H; Kanis JA
J Clin Oncol; 1995 Apr; 13(4):929-34. PubMed ID: 7707121
[TBL] [Abstract][Full Text] [Related]
33. The effect of two different doses of oral clodronate on pain in patients with bone metastases.
Arican A; Içli F; Akbulut H; Cakir M; Sencan O; Samur M; Açikgöz N; Demirkazik A
Med Oncol; 1999 Sep; 16(3):204-10. PubMed ID: 10523801
[TBL] [Abstract][Full Text] [Related]
34. Radiopharmaceuticals for the palliation of painful bone metastases.
Sinclair JM
Am J Hosp Palliat Care; 2005; 22(5):338. PubMed ID: 16225354
[No Abstract] [Full Text] [Related]
35. [Parenteral disodium-clodronate in patients with rheumatoid arthritis. A two-month open clinical study].
Rovetta G; Monteforte P; Molfetta L
Minerva Med; 2001 Dec; 92(6):417-9. PubMed ID: 11740429
[TBL] [Abstract][Full Text] [Related]
36. The use of bisphosphonates in palliative treatment of bone metastases in a terminally ill, oncological elderly population.
Santangelo A; Testai M; Barbagallo P; Manuele S; Di Stefano A; Tomarchio M; Trizzino G; Musumeci G; Panebianco P; Maugeri D
Arch Gerontol Geriatr; 2006; 43(2):187-92. PubMed ID: 16325938
[TBL] [Abstract][Full Text] [Related]
37. Safety of intravenous and oral bisphosphonates and compliance with dosing regimens.
Conte P; Guarneri V
Oncologist; 2004; 9 Suppl 4():28-37. PubMed ID: 15459427
[TBL] [Abstract][Full Text] [Related]
38. Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancer.
Kylmälä T; Taube T; Tammela TL; Risteli L; Risteli J; Elomaa I
Br J Cancer; 1997; 76(7):939-42. PubMed ID: 9328156
[TBL] [Abstract][Full Text] [Related]
39. Current and future status of adjuvant therapy for breast cancer.
Coleman RE
Cancer; 2003 Feb; 97(3 Suppl):880-6. PubMed ID: 12548590
[TBL] [Abstract][Full Text] [Related]
40. Transient relief of metastatic cancer bone pain by oral administration of etidronate.
Iwamoto J; Takeda T; Ichimura S
J Bone Miner Metab; 2002; 20(4):228-34. PubMed ID: 12115069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
